This is nicely illustrated by the implementation processes of several strategies in the ICU in the last decade, such as the use of recombinant human-activated protein C (rh-APC) in severe sepsis [25], and the use of lung-protective mechanical ventilation in patients with acute lung injury [26] (Table 2). The gene discussed is APC; the disease is injury.